Attention deficit hyperactivity disorder and Haemoglobin decreased

Summary:

Haemoglobin decreased is found among people with Attention deficit hyperactivity disorder, especially for people who are male, 10-19 old.

The study analyzes which people have Haemoglobin decreased with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 76 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 608 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,398 drugs and 3,137 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

76 people who have Attention Deficit Hyperactivity Disorder and Haemoglobin Decreased are studied.

Would you have Haemoglobin decreased when you have Attention deficit hyperactivity disorder?

Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Haemoglobin Decreased *:

female: 42.67 %
male: 57.33 %

Age of people who have Attention Deficit Hyperactivity Disorder and experienced Haemoglobin Decreased *:

Common co-existing conditions for these people *:

Depression: 17 people, 22.37%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 15.79%
Stress And Anxiety: 8 people, 10.53%
High Blood Pressure: 7 people, 9.21%
Migraine (headache): 6 people, 7.89%
Pain: 5 people, 6.58%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.58%
Insomnia (sleeplessness): 5 people, 6.58%
Bipolar Disorder (mood disorder): 5 people, 6.58%
High Blood Cholesterol: 4 people, 5.26%

Common drugs taken by these people *:

Common symptoms for these people *:

Haematocrit Decreased: 21 people, 27.63%
White Blood Cell Count Decreased: 14 people, 18.42%
Fatigue (feeling of tiredness): 14 people, 18.42%
Red Blood Cell Count Decreased: 14 people, 18.42%
Thrombocytopenia (decrease of platelets in blood): 13 people, 17.11%
Hypotension (abnormally low blood pressure): 11 people, 14.47%
Diarrhea: 10 people, 13.16%
Gastric Ulcer (stomach ulcer): 10 people, 13.16%
Stress And Anxiety: 9 people, 11.84%
Headache (pain in head): 9 people, 11.84%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haemoglobin decreased and Attention deficit hyperactivity disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.